A review of the health and economic implications of patent protection, with a specific focus on Thailand
Open Access
- 1 August 2012
- journal article
- review article
- Published by Springer Nature in Health Research Policy and Systems
- Vol. 10 (1) , 24
Abstract
Although it has been two decades since the Thai Patent Act was amended to comply with the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), there has been little emphasis given to assessing the implications of this amendment. The purpose of this review is to summarize the health and economic impact of patent protection, with a focus on the experience of Thailand.Keywords
This publication has 44 references indexed in Scilit:
- Extension of market exclusivity and its impact on the accessibility to essential medicines, and drug expense in Thailand: Analysis of the effect of TRIPs-Plus proposalHealth Policy, 2009
- Location Strategies of Foreign Investors in China: Evidence from Japanese Manufacturing MultinationalsGlobal Economic Review, 2009
- Trade, TRIPS, and pharmaceuticalsThe Lancet, 2009
- Duration of Rent Extraction and the Entry Mode Decision of Multinational EnterprisesReview of Development Economics, 2008
- Pricing and patents of HIV/AIDS drugs in developing countriesApplied Economics, 2007
- Global public goods and the global health agenda: problems, priorities and potentialGlobalization and Health, 2007
- Patent protection and foreign direct investmentThunderbird International Business Review, 2006
- Drug Prices and Research and Development Investment Behavior in the Pharmaceutical IndustryThe Journal of Law and Economics, 2005
- How Do Patents And Economic Policies Affect Access To Essential Medicines In Developing Countries?Health Affairs, 2004
- Pharmaceutical Patents, Prices and Welfare Losses: Policy Options for India Under the WTO TRIPS AgreementThe World Economy, 2000